Search research articles
Contact Us
Filters
Showing results (161-170 of 236) with videos related to
Page
of 24
Sort By:
Metabolism: Clinical and Experimental
|
February 18, 2024
Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation
Simran Pherwani, David Connolly, Qiuyu Sun, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
October 1, 2023
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuum
T Jake Samuel, Andrew P Oneglia, Daisha J Cipher, et al.
Circulation Research
|
April 24, 2004
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation
Jason R B Dyck, Jie-Fei Cheng, William C Stanley, et al.
Molecular and Cellular Biology
|
December 14, 2011
Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction
Petra C Kienesberger, Thomas Pulinilkunnil, Miranda M Y Sung, et al.
Cardiovascular Research
|
March 23, 2018
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
Nobutoshi Matsumura, Beshay N Zordoky, Ian M Robertson, et al.
Journal of Molecular and Cellular Cardiology
|
December 4, 2012
Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway
Benjamin Lauzier, Fanny Vaillant, Clemence Merlen, et al.
Cardiovascular Research
|
May 28, 2013
Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation
Petra C Kienesberger, Thomas Pulinilkunnil, Jeevan Nagendran, et al.
Atherosclerosis
|
May 4, 2012
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism
Danna M Breen, Vernon W Dolinsky, Hangjun Zhang, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents
Jie-Fei Cheng, Yujin Huang, Richard Penuliar, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
Mohamed Salla, Jimmy Guo, Harshad Joshi, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 236) with videos related to
Sort By:
Page
of 24
Metabolism: Clinical and Experimental
|
February 18, 2024
Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation
Simran Pherwani, David Connolly, Qiuyu Sun, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
October 1, 2023
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuum
T Jake Samuel, Andrew P Oneglia, Daisha J Cipher, et al.
Circulation Research
|
April 24, 2004
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation
Jason R B Dyck, Jie-Fei Cheng, William C Stanley, et al.
Molecular and Cellular Biology
|
December 14, 2011
Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction
Petra C Kienesberger, Thomas Pulinilkunnil, Miranda M Y Sung, et al.
Cardiovascular Research
|
March 23, 2018
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
Nobutoshi Matsumura, Beshay N Zordoky, Ian M Robertson, et al.
Journal of Molecular and Cellular Cardiology
|
December 4, 2012
Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway
Benjamin Lauzier, Fanny Vaillant, Clemence Merlen, et al.
Cardiovascular Research
|
May 28, 2013
Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation
Petra C Kienesberger, Thomas Pulinilkunnil, Jeevan Nagendran, et al.
Atherosclerosis
|
May 4, 2012
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism
Danna M Breen, Vernon W Dolinsky, Hangjun Zhang, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents
Jie-Fei Cheng, Yujin Huang, Richard Penuliar, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
Mohamed Salla, Jimmy Guo, Harshad Joshi, et al.
Page
of 24